Quality of life assessment in gynaecological cancer patients

J. Carter, A. Saltzman, D. Chen, P. Carney, P. Johnson, E. Hartenbach, J. Fowler, L. Carson, L. Twiggs

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The feasibility of quality of life (QOL) assessment in a heterogeneous group of gynaecological cancer patients undergoing chemotherapy was determined. All new patients being prescribed cytotoxic chemotherapy were asked to complete a modified QOL assessment tool. The elected assessment tool is the Functional Assessment Cancer Therapy-General (FACT-G) tool, comprising 33 questions under 5 broad categories: physical well-being, social well-being, relationship with doctor, emotional well-being and functional well-being. Raw scores were calculated and then transformed to a 0-100 scale. Twenty eight patients received a total of 75 treatment cycles of chemotherapy. Four patients were not offered the assessment due to language difficulties. All patients offered the test satisfactorily completed the test to allow statistical analysis. The average number of chemotherapy courses received was 2.5 (range: 1-6). Of a total possible 2,475 study items (33 items x 75 cycles), 240 items were not answered (10%). Of these 240 unanswered items, 2 items (14 and 15) comprised 38%. The mean transformed score for physical well-being was 32 (SE 2.5), for social well-being the mean transformed score was 50 (SE 1.7), relationship with doctor 86 (SE 2.4), emotional well-being 41 (SE 2) and functional well-being was 54 (SE 2.6). The assessment of QOL indices in gynaecological cancer patients undergoing chemotherapy is feasible. Further research needs to determine the optimal QOL tool for this patient population.

Original languageEnglish
Pages (from-to)293-297
Number of pages5
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume35
Issue number3
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Quality of Life
Drug Therapy
Neoplasms
Language
Therapeutics
Research
Population

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Carter, J., Saltzman, A., Chen, D., Carney, P., Johnson, P., Hartenbach, E., ... Twiggs, L. (1995). Quality of life assessment in gynaecological cancer patients. Australian and New Zealand Journal of Obstetrics and Gynaecology, 35(3), 293-297.

Quality of life assessment in gynaecological cancer patients. / Carter, J.; Saltzman, A.; Chen, D.; Carney, P.; Johnson, P.; Hartenbach, E.; Fowler, J.; Carson, L.; Twiggs, L.

In: Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 35, No. 3, 01.01.1995, p. 293-297.

Research output: Contribution to journalArticle

Carter, J, Saltzman, A, Chen, D, Carney, P, Johnson, P, Hartenbach, E, Fowler, J, Carson, L & Twiggs, L 1995, 'Quality of life assessment in gynaecological cancer patients', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 35, no. 3, pp. 293-297.
Carter J, Saltzman A, Chen D, Carney P, Johnson P, Hartenbach E et al. Quality of life assessment in gynaecological cancer patients. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1995 Jan 1;35(3):293-297.
Carter, J. ; Saltzman, A. ; Chen, D. ; Carney, P. ; Johnson, P. ; Hartenbach, E. ; Fowler, J. ; Carson, L. ; Twiggs, L. / Quality of life assessment in gynaecological cancer patients. In: Australian and New Zealand Journal of Obstetrics and Gynaecology. 1995 ; Vol. 35, No. 3. pp. 293-297.
@article{ce9dc6e1caed455c834caaa9fb53ab93,
title = "Quality of life assessment in gynaecological cancer patients",
abstract = "The feasibility of quality of life (QOL) assessment in a heterogeneous group of gynaecological cancer patients undergoing chemotherapy was determined. All new patients being prescribed cytotoxic chemotherapy were asked to complete a modified QOL assessment tool. The elected assessment tool is the Functional Assessment Cancer Therapy-General (FACT-G) tool, comprising 33 questions under 5 broad categories: physical well-being, social well-being, relationship with doctor, emotional well-being and functional well-being. Raw scores were calculated and then transformed to a 0-100 scale. Twenty eight patients received a total of 75 treatment cycles of chemotherapy. Four patients were not offered the assessment due to language difficulties. All patients offered the test satisfactorily completed the test to allow statistical analysis. The average number of chemotherapy courses received was 2.5 (range: 1-6). Of a total possible 2,475 study items (33 items x 75 cycles), 240 items were not answered (10{\%}). Of these 240 unanswered items, 2 items (14 and 15) comprised 38{\%}. The mean transformed score for physical well-being was 32 (SE 2.5), for social well-being the mean transformed score was 50 (SE 1.7), relationship with doctor 86 (SE 2.4), emotional well-being 41 (SE 2) and functional well-being was 54 (SE 2.6). The assessment of QOL indices in gynaecological cancer patients undergoing chemotherapy is feasible. Further research needs to determine the optimal QOL tool for this patient population.",
author = "J. Carter and A. Saltzman and D. Chen and P. Carney and P. Johnson and E. Hartenbach and J. Fowler and L. Carson and L. Twiggs",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "293--297",
journal = "Australian and New Zealand Journal of Obstetrics and Gynaecology",
issn = "0004-8666",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Quality of life assessment in gynaecological cancer patients

AU - Carter, J.

AU - Saltzman, A.

AU - Chen, D.

AU - Carney, P.

AU - Johnson, P.

AU - Hartenbach, E.

AU - Fowler, J.

AU - Carson, L.

AU - Twiggs, L.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The feasibility of quality of life (QOL) assessment in a heterogeneous group of gynaecological cancer patients undergoing chemotherapy was determined. All new patients being prescribed cytotoxic chemotherapy were asked to complete a modified QOL assessment tool. The elected assessment tool is the Functional Assessment Cancer Therapy-General (FACT-G) tool, comprising 33 questions under 5 broad categories: physical well-being, social well-being, relationship with doctor, emotional well-being and functional well-being. Raw scores were calculated and then transformed to a 0-100 scale. Twenty eight patients received a total of 75 treatment cycles of chemotherapy. Four patients were not offered the assessment due to language difficulties. All patients offered the test satisfactorily completed the test to allow statistical analysis. The average number of chemotherapy courses received was 2.5 (range: 1-6). Of a total possible 2,475 study items (33 items x 75 cycles), 240 items were not answered (10%). Of these 240 unanswered items, 2 items (14 and 15) comprised 38%. The mean transformed score for physical well-being was 32 (SE 2.5), for social well-being the mean transformed score was 50 (SE 1.7), relationship with doctor 86 (SE 2.4), emotional well-being 41 (SE 2) and functional well-being was 54 (SE 2.6). The assessment of QOL indices in gynaecological cancer patients undergoing chemotherapy is feasible. Further research needs to determine the optimal QOL tool for this patient population.

AB - The feasibility of quality of life (QOL) assessment in a heterogeneous group of gynaecological cancer patients undergoing chemotherapy was determined. All new patients being prescribed cytotoxic chemotherapy were asked to complete a modified QOL assessment tool. The elected assessment tool is the Functional Assessment Cancer Therapy-General (FACT-G) tool, comprising 33 questions under 5 broad categories: physical well-being, social well-being, relationship with doctor, emotional well-being and functional well-being. Raw scores were calculated and then transformed to a 0-100 scale. Twenty eight patients received a total of 75 treatment cycles of chemotherapy. Four patients were not offered the assessment due to language difficulties. All patients offered the test satisfactorily completed the test to allow statistical analysis. The average number of chemotherapy courses received was 2.5 (range: 1-6). Of a total possible 2,475 study items (33 items x 75 cycles), 240 items were not answered (10%). Of these 240 unanswered items, 2 items (14 and 15) comprised 38%. The mean transformed score for physical well-being was 32 (SE 2.5), for social well-being the mean transformed score was 50 (SE 1.7), relationship with doctor 86 (SE 2.4), emotional well-being 41 (SE 2) and functional well-being was 54 (SE 2.6). The assessment of QOL indices in gynaecological cancer patients undergoing chemotherapy is feasible. Further research needs to determine the optimal QOL tool for this patient population.

UR - http://www.scopus.com/inward/record.url?scp=0029022122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029022122&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 293

EP - 297

JO - Australian and New Zealand Journal of Obstetrics and Gynaecology

JF - Australian and New Zealand Journal of Obstetrics and Gynaecology

SN - 0004-8666

IS - 3

ER -